Загрузка...
Oligoclonal Antibodies to Target the ErbB Family
INTRODUCTION: Use of monoclonal antibodies to inhibit signaling through the ErbB receptor tyrosine kinase family has proven to be an effective strategy for treating ErbB-driven cancers. Advances in the field of antibody engineering and manufacturing now allow us to more effectively mimic the natural...
Сохранить в:
| Опубликовано в: : | Expert Opin Biol Ther |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4480362/ https://ncbi.nlm.nih.gov/pubmed/25936923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2015.1042362 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|